Rare	O
Pedal	B:C0016504
Manifestation	O
of	O
Diffuse	O
Multiple	O
Myeloma	I:C0026764
Lesions	O
Multiple	O
myeloma	I:C0026764
is	O
a	O
malignancy	O
of	O
plasma	O
cell	O
proliferation	I:C0596290
leading	O
to	O
production	O
of	O
monoclonal	O
immunoglobins	I:C0003250
.	O

Rare	O
Pedal	O
Manifestation	O
of	O
Diffuse	B:C0205219
Multiple	O
Myeloma	I:C0026764
Lesions	O
Multiple	O
myeloma	I:C0026764
is	O
a	O
malignancy	O
of	O
plasma	O
cell	O
proliferation	I:C0596290
leading	O
to	O
production	O
of	O
monoclonal	O
immunoglobins	I:C0003250
.	O

Rare	O
Pedal	O
Manifestation	O
of	O
Diffuse	O
Multiple	B:C0026764
Myeloma	I:C0026764
Lesions	O
Multiple	O
myeloma	I:C0026764
is	O
a	O
malignancy	O
of	O
plasma	O
cell	O
proliferation	I:C0596290
leading	O
to	O
production	O
of	O
monoclonal	O
immunoglobins	I:C0003250
.	O

Rare	O
Pedal	O
Manifestation	O
of	O
Diffuse	O
Multiple	O
Myeloma	I:C0026764
Lesions	B:C0238792
Multiple	O
myeloma	I:C0026764
is	O
a	O
malignancy	O
of	O
plasma	O
cell	O
proliferation	I:C0596290
leading	O
to	O
production	O
of	O
monoclonal	O
immunoglobins	I:C0003250
.	O

Rare	O
Pedal	O
Manifestation	O
of	O
Diffuse	O
Multiple	O
Myeloma	I:C0026764
Lesions	O
Multiple	B:C0026764
myeloma	I:C0026764
is	O
a	O
malignancy	O
of	O
plasma	O
cell	O
proliferation	I:C0596290
leading	O
to	O
production	O
of	O
monoclonal	O
immunoglobins	I:C0003250
.	O

Rare	O
Pedal	O
Manifestation	O
of	O
Diffuse	O
Multiple	O
Myeloma	I:C0026764
Lesions	O
Multiple	O
myeloma	I:C0026764
is	O
a	O
malignancy	B:C4282132
of	O
plasma	O
cell	O
proliferation	I:C0596290
leading	O
to	O
production	O
of	O
monoclonal	O
immunoglobins	I:C0003250
.	O

Rare	O
Pedal	O
Manifestation	O
of	O
Diffuse	O
Multiple	O
Myeloma	I:C0026764
Lesions	O
Multiple	O
myeloma	I:C0026764
is	O
a	O
malignancy	O
of	O
plasma	B:C0032105
cell	O
proliferation	I:C0596290
leading	O
to	O
production	O
of	O
monoclonal	O
immunoglobins	I:C0003250
.	O

Rare	O
Pedal	O
Manifestation	O
of	O
Diffuse	O
Multiple	O
Myeloma	I:C0026764
Lesions	O
Multiple	O
myeloma	I:C0026764
is	O
a	O
malignancy	O
of	O
plasma	O
cell	B:C0596290
proliferation	I:C0596290
leading	O
to	O
production	O
of	O
monoclonal	O
immunoglobins	I:C0003250
.	O

Rare	O
Pedal	O
Manifestation	O
of	O
Diffuse	O
Multiple	O
Myeloma	I:C0026764
Lesions	O
Multiple	O
myeloma	I:C0026764
is	O
a	O
malignancy	O
of	O
plasma	O
cell	O
proliferation	I:C0596290
leading	O
to	O
production	O
of	O
monoclonal	B:C0003250
immunoglobins	I:C0003250
.	O

Among	O
the	O
classic	O
features	O
of	O
multiple	B:C0026764
myeloma	I:C0026764
are	O
bone	O
lesions	I:C0238792
,	O
which	O
typically	O
manifest	O
in	O
the	O
axial	O
skeleton	I:C0222645
,	O
vertebrae	O
,	O
pelvis	O
,	O
skull	O
,	O
ribs	O
,	O
and	O
proximal	O
extremities	O
.	O

Among	O
the	O
classic	O
features	O
of	O
multiple	O
myeloma	I:C0026764
are	O
bone	B:C0238792
lesions	I:C0238792
,	O
which	O
typically	O
manifest	O
in	O
the	O
axial	O
skeleton	I:C0222645
,	O
vertebrae	O
,	O
pelvis	O
,	O
skull	O
,	O
ribs	O
,	O
and	O
proximal	O
extremities	O
.	O

Among	O
the	O
classic	O
features	O
of	O
multiple	O
myeloma	I:C0026764
are	O
bone	O
lesions	I:C0238792
,	O
which	O
typically	O
manifest	O
in	O
the	O
axial	B:C0222645
skeleton	I:C0222645
,	O
vertebrae	O
,	O
pelvis	O
,	O
skull	O
,	O
ribs	O
,	O
and	O
proximal	O
extremities	O
.	O

Among	O
the	O
classic	O
features	O
of	O
multiple	O
myeloma	I:C0026764
are	O
bone	O
lesions	I:C0238792
,	O
which	O
typically	O
manifest	O
in	O
the	O
axial	O
skeleton	I:C0222645
,	O
vertebrae	B:C0549207
,	O
pelvis	O
,	O
skull	O
,	O
ribs	O
,	O
and	O
proximal	O
extremities	O
.	O

Among	O
the	O
classic	O
features	O
of	O
multiple	O
myeloma	I:C0026764
are	O
bone	O
lesions	I:C0238792
,	O
which	O
typically	O
manifest	O
in	O
the	O
axial	O
skeleton	I:C0222645
,	O
vertebrae	O
,	O
pelvis	B:C0030797
,	O
skull	O
,	O
ribs	O
,	O
and	O
proximal	O
extremities	O
.	O

Among	O
the	O
classic	O
features	O
of	O
multiple	O
myeloma	I:C0026764
are	O
bone	O
lesions	I:C0238792
,	O
which	O
typically	O
manifest	O
in	O
the	O
axial	O
skeleton	I:C0222645
,	O
vertebrae	O
,	O
pelvis	O
,	O
skull	B:C2951888
,	O
ribs	O
,	O
and	O
proximal	O
extremities	O
.	O

Among	O
the	O
classic	O
features	O
of	O
multiple	O
myeloma	I:C0026764
are	O
bone	O
lesions	I:C0238792
,	O
which	O
typically	O
manifest	O
in	O
the	O
axial	O
skeleton	I:C0222645
,	O
vertebrae	O
,	O
pelvis	O
,	O
skull	O
,	O
ribs	B:C0035561
,	O
and	O
proximal	O
extremities	O
.	O

Among	O
the	O
classic	O
features	O
of	O
multiple	O
myeloma	I:C0026764
are	O
bone	O
lesions	I:C0238792
,	O
which	O
typically	O
manifest	O
in	O
the	O
axial	O
skeleton	I:C0222645
,	O
vertebrae	O
,	O
pelvis	O
,	O
skull	O
,	O
ribs	O
,	O
and	O
proximal	B:C0205107
extremities	O
.	O

Among	O
the	O
classic	O
features	O
of	O
multiple	O
myeloma	I:C0026764
are	O
bone	O
lesions	I:C0238792
,	O
which	O
typically	O
manifest	O
in	O
the	O
axial	O
skeleton	I:C0222645
,	O
vertebrae	O
,	O
pelvis	O
,	O
skull	O
,	O
ribs	O
,	O
and	O
proximal	O
extremities	B:C0015385
.	O

The	O
several	O
types	O
of	O
multiple	B:C0026764
myeloma	I:C0026764
include	O
symptomatic	O
multiple	O
myeloma	I:C0026764
,	O
monoclonal	O
gammopathy	I:C1136085
of	O
undetermined	O
significance	O
,	O
smoldering	O
/	O
indolent	O
myeloma	I:C1334169
,	O
and	O
solitary	O
plasmacytoma	I:C0032131
of	I:C0032131
bone	I:C0032131
.	O

The	O
several	O
types	O
of	O
multiple	O
myeloma	I:C0026764
include	O
symptomatic	O
multiple	B:C0026764
myeloma	I:C0026764
,	O
monoclonal	O
gammopathy	I:C1136085
of	O
undetermined	O
significance	O
,	O
smoldering	O
/	O
indolent	O
myeloma	I:C1334169
,	O
and	O
solitary	O
plasmacytoma	I:C0032131
of	I:C0032131
bone	I:C0032131
.	O

The	O
several	O
types	O
of	O
multiple	O
myeloma	I:C0026764
include	O
symptomatic	O
multiple	O
myeloma	I:C0026764
,	O
monoclonal	B:C1136085
gammopathy	I:C1136085
of	O
undetermined	O
significance	O
,	O
smoldering	O
/	O
indolent	O
myeloma	I:C1334169
,	O
and	O
solitary	O
plasmacytoma	I:C0032131
of	I:C0032131
bone	I:C0032131
.	O

The	O
several	O
types	O
of	O
multiple	O
myeloma	I:C0026764
include	O
symptomatic	O
multiple	O
myeloma	I:C0026764
,	O
monoclonal	O
gammopathy	I:C1136085
of	O
undetermined	O
significance	O
,	O
smoldering	B:C1531608
/	O
indolent	O
myeloma	I:C1334169
,	O
and	O
solitary	O
plasmacytoma	I:C0032131
of	I:C0032131
bone	I:C0032131
.	O

The	O
several	O
types	O
of	O
multiple	O
myeloma	I:C0026764
include	O
symptomatic	O
multiple	O
myeloma	I:C0026764
,	O
monoclonal	O
gammopathy	I:C1136085
of	O
undetermined	O
significance	O
,	O
smoldering	O
/	O
indolent	B:C1334169
myeloma	I:C1334169
,	O
and	O
solitary	O
plasmacytoma	I:C0032131
of	I:C0032131
bone	I:C0032131
.	O

The	O
several	O
types	O
of	O
multiple	O
myeloma	I:C0026764
include	O
symptomatic	O
multiple	O
myeloma	I:C0026764
,	O
monoclonal	O
gammopathy	I:C1136085
of	O
undetermined	O
significance	O
,	O
smoldering	O
/	O
indolent	O
myeloma	I:C1334169
,	O
and	O
solitary	B:C0032131
plasmacytoma	I:C0032131
of	I:C0032131
bone	I:C0032131
.	O

Although	O
rare	O
,	O
plasmacytomas	B:C0032131
of	O
the	O
foot	O
and	O
ankle	O
have	O
been	O
described	O
in	O
published	O
studies	O
.	O

Although	O
rare	O
,	O
plasmacytomas	O
of	O
the	O
foot	B:C0016504
and	O
ankle	O
have	O
been	O
described	O
in	O
published	O
studies	O
.	O

Although	O
rare	O
,	O
plasmacytomas	O
of	O
the	O
foot	O
and	O
ankle	B:C0003086
have	O
been	O
described	O
in	O
published	O
studies	O
.	O

We	O
present	O
,	O
to	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
the	O
first	O
description	O
of	O
classic	O
diffuse	B:C0205219
myelomatosis	O
lesions	O
associated	O
with	O
symptomatic	O
myeloma	O
in	O
the	O
foot	O
of	O
a	O
patient	O
with	O
advanced	O
disease	O
who	O
was	O
treated	O
in	O
the	O
podiatric	O
surgery	I:C0543467
clinic	O
for	O
pathologic	O
fracture	I:C0016663
.	O

We	O
present	O
,	O
to	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
the	O
first	O
description	O
of	O
classic	O
diffuse	O
myelomatosis	B:C0026764
lesions	O
associated	O
with	O
symptomatic	O
myeloma	O
in	O
the	O
foot	O
of	O
a	O
patient	O
with	O
advanced	O
disease	O
who	O
was	O
treated	O
in	O
the	O
podiatric	O
surgery	I:C0543467
clinic	O
for	O
pathologic	O
fracture	I:C0016663
.	O

We	O
present	O
,	O
to	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
the	O
first	O
description	O
of	O
classic	O
diffuse	O
myelomatosis	O
lesions	B:C0238792
associated	O
with	O
symptomatic	O
myeloma	O
in	O
the	O
foot	O
of	O
a	O
patient	O
with	O
advanced	O
disease	O
who	O
was	O
treated	O
in	O
the	O
podiatric	O
surgery	I:C0543467
clinic	O
for	O
pathologic	O
fracture	I:C0016663
.	O

We	O
present	O
,	O
to	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
the	O
first	O
description	O
of	O
classic	O
diffuse	O
myelomatosis	O
lesions	O
associated	O
with	O
symptomatic	O
myeloma	B:C0026764
in	O
the	O
foot	O
of	O
a	O
patient	O
with	O
advanced	O
disease	O
who	O
was	O
treated	O
in	O
the	O
podiatric	O
surgery	I:C0543467
clinic	O
for	O
pathologic	O
fracture	I:C0016663
.	O

We	O
present	O
,	O
to	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
the	O
first	O
description	O
of	O
classic	O
diffuse	O
myelomatosis	O
lesions	O
associated	O
with	O
symptomatic	O
myeloma	O
in	O
the	O
foot	B:C0016504
of	O
a	O
patient	O
with	O
advanced	O
disease	O
who	O
was	O
treated	O
in	O
the	O
podiatric	O
surgery	I:C0543467
clinic	O
for	O
pathologic	O
fracture	I:C0016663
.	O

We	O
present	O
,	O
to	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
the	O
first	O
description	O
of	O
classic	O
diffuse	O
myelomatosis	O
lesions	O
associated	O
with	O
symptomatic	O
myeloma	O
in	O
the	O
foot	O
of	O
a	O
patient	O
with	O
advanced	O
disease	O
who	O
was	O
treated	O
in	O
the	O
podiatric	B:C0543467
surgery	I:C0543467
clinic	O
for	O
pathologic	O
fracture	I:C0016663
.	O

We	O
present	O
,	O
to	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
the	O
first	O
description	O
of	O
classic	O
diffuse	O
myelomatosis	O
lesions	O
associated	O
with	O
symptomatic	O
myeloma	O
in	O
the	O
foot	O
of	O
a	O
patient	O
with	O
advanced	O
disease	O
who	O
was	O
treated	O
in	O
the	O
podiatric	O
surgery	I:C0543467
clinic	B:C0442592
for	O
pathologic	O
fracture	I:C0016663
.	O

We	O
present	O
,	O
to	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
the	O
first	O
description	O
of	O
classic	O
diffuse	O
myelomatosis	O
lesions	O
associated	O
with	O
symptomatic	O
myeloma	O
in	O
the	O
foot	O
of	O
a	O
patient	O
with	O
advanced	O
disease	O
who	O
was	O
treated	O
in	O
the	O
podiatric	O
surgery	I:C0543467
clinic	O
for	O
pathologic	B:C0016663
fracture	I:C0016663
.	O

